H
Hospital Agamenon Magalhaes | Research Center
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
PF-07321332
Ritonavir
Empagliflozin
Bococizumab
Heparin
Ticagrelor
Maridebart Cafraglutide
Olpasiran
EMPagliflozin
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 12 total trials
The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of car...
Enrolling
Overweight
Atherosclerotic Cardiovascular Disease
Drug: Maridebart Cafraglutide
Drug: Placebo
The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (C...
Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo
Trial sponsors
U
H
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems